The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Deficit and nondeficit forms of schizophrenia: the concept
Abstract
The authors provide a rationale for distinguishing the primary, enduring negative symptoms of schizophrenia (termed "deficit symptoms") from the more transient negative symptoms secondary to other factors. They argue that the former are more likely to provide a basis for meaningful subtyping of the schizophrenic syndrome, while the latter are more likely to respond to currently available treatments. They describe their experience in using clinical judgment based on longitudinal observations to identify deficit and nondeficit subtypes of schizophrenic patients and propose criteria for defining schizophrenia with the deficit syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,901
Negative v Positive Schizophrenia: Definition and Validation
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,012
Molecular pathology of schizophrenia: more than one disease process?
Crow, T. J. (1980) · BMJ · doi:10.1136/bmj.280.6207.66 · Cited by 1,856
Geschwind, N. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060060019009 · Cited by 1,714
Geschwind, N. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060050026008 · Cited by 1,440
The Two-syndrome Concept: Origins and Current Status
Crow, T. J. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.471 · Cited by 839
Institutionalism and Schizophrenia: A Comparative Study of Three Mental Hospitals 1960-1968
Wing, J. K., & Brown, G. W. (1970) · Cambridge University Press eBooks · doi:10.1017/cbo9780511753374 · Cited by 828
Strauss, J. S. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760130021003 · Cited by 643
Part III. Speculations on the Processes That Underlie Schizophrenic Symptoms and Signs
Strauss, J. S., Carpenter, W. T., & Bartko, J. J. (1974) · Schizophrenia Bulletin · doi:10.1093/schbul/1.11.61 · Cited by 574
Cited by
The NIMH-MATRICS Consensus Statement on Negative Symptoms
Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj053 · Cited by 1,311
Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,027
Awareness of Illness in Schizophrenia and Schizoaffective and Mood Disorders
Amador, X. F. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950100074007 · Cited by 896
McGorry, P. D., Hickie, I. B., Yung, A. R., Pantelis, C., & Jackson, H. J. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01860.x · Cited by 919
Andreasen, N. C. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120031006 · Cited by 885
The schedule for the deficit syndrome: An instrument for research in schizophrenia
Kirkpatrick, B., Buchanan, R. W., McKenny, P. D., Alphs, L. D., & Carpenter, W. T. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90153-4 · Cited by 808
Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms
Andreasen, N. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950170015003 · Cited by 734
Stress-reactivity in psychosis: Evidence for an affective pathway to psychosis
Myin-Germeys, I., & van Os, J. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.09.005 · Cited by 719
Kapur, S., Zipursky, R. B., & Remington, G. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.286 · Cited by 712
Fusar-Poli, P., Papanastasiou, E., Stahl, D., Rocchetti, M., Carpenter, W., Shergill, S., & McGuire, P. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu170 · Cited by 683
A Separate Disease Within the Syndrome of Schizophrenia
Kirkpatrick, B., Buchanan, R. W., Ross, D. E., & Carpenter, W. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.2.165 · Cited by 651
The Structure of Negative Symptoms Within Schizophrenia: Implications for Assessment
Blanchard, J. J., & Cohen, A. S. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj013 · Cited by 649
Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
Foussias, G., & Remington, G. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn094 · Cited by 594
Pantelis, C. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi034 · Cited by 573
Javitt, D. C. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78003-5 · Cited by 560
Negative symptoms of schizophrenia: new developments and unanswered research questions
Galderisi, S., Mucci, A., Buchanan, R. W., & Arango, C. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30050-6 · Cited by 555
Gur, R. E., Cowell, P., Turetsky, B. I., Gallacher, F., Cannon, T., Bilker, W., & Gur, R. C. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.145 · Cited by 540
The current conceptualization of negative symptoms in schizophrenia
Marder, S. R., & Galderisi, S. (2017) · World Psychiatry · doi:10.1002/wps.20385 · Cited by 537
Is it possible to be schizophrenic yet neuropsychologically normal?
Palmer, B. W., Heaton, R. K., Paulsen, J. S., Kuck, J., Harris, M. J., Zisook, S., & Jeste, D. V. (1997) · Neuropsychology · doi:10.1037//0894-4105.11.3.437 · Cited by 529
Efficacy of High-Dose Glycine in the Treatment of Enduring Negative Symptoms of Schizophrenia
Heresco-Levy, U., Javitt, D. C., Ermilov, M., Mordel, C., Silipo, G., & Lichtenstein, M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.29 · Cited by 487
A Review of Reward Processing and Motivational Impairment in Schizophrenia
Strauss, G. P., Waltz, J. A., & Gold, J. M. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt197 · Cited by 452
Persistent Negative Symptoms in Schizophrenia: An Overview
Buchanan, R. W. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl057 · Cited by 443
Time Course and Biologic Correlates of Treatment Response in First-Episode Schizophrenia
Lieberman, J. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820170047006 · Cited by 442
Goff, D. C., Tsai, G., Levitt, J., Amico, E., Manoach, D., Schoenfeld, D. A., Hayden, D. L., McCarley, R., & Coyle, J. T. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.21 · Cited by 436
An Analysis of Social Competence in Schizophrenia
Bellack, A. S., Morrison, R. L., Wixted, J. T., & Mueser, K. T. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.156.6.809 · Cited by 426
Strauss, G. P., Horan, W. P., Kirkpatrick, B., Fischer, B. A., Keller, W. R., Miski, P., Buchanan, R. W., Green, M. F., & Carpenter, W. T. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.01.015 · Cited by 422
Grant, P. M., & Beck, A. T. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn008 · Cited by 421
Early Detection and Intervention With Schizophrenia: Rationale
McGlashan, T. H., & Johannessen, J. O. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.2.201 · Cited by 419
Schizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 409
Oda, Y. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00977.x · Cited by 400
Ranjekar, P. K., Hinge, A., Hegde, M. V., Ghate, M., Kale, A., Sitasawad, S., Wagh, U. V., Debsikdar, V. B., & Mahadik, S. P. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00220-8 · Cited by 395
Weiner, I. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1313-x · Cited by 391
Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.1.20 · Cited by 388
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?
McGlashan, T. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00084-0 · Cited by 374
Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia
Gur, R. E., Cowell, P. E., Latshaw, A., Turetsky, B. I., Grossman, R. I., Arnold, S. E., Bilker, W. B., & Gur, R. C. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.761 · Cited by 368
Temporolimbic Volume Reductions in Schizophrenia
Gur, R. E., Turetsky, B. I., Cowell, P. E., Finkelman, C., Maany, V., Grossman, R. I., Arnold, S. E., Bilker, W. B., & Gur, R. C. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.769 · Cited by 357
Amelioration of negative symptoms in schizophrenia by glycine
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1234 · Cited by 354
Tandon, R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810080075010 · Cited by 351
Millan, M. J., Fone, K., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 347
The Continuum of Psychotic Symptoms in the General Population: A Cross-national Study
Nuevo, R., Chatterji, S., Verdes, E., Naidoo, N., Arango, C., & Ayuso-Mateos, J. L. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq099 · Cited by 340
Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia
Bogerts, B., Lieberman, J. A., Ashtari, M., Bilder, R. M., Degreef, G., Lerner, G., Johns, C., & Masiar, S. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90289-p · Cited by 338
Psychiatric genetics: search for phenotypes
Leboyer, M., Leboyer, M., Bellivier, F., Jouvent, R., Nosten-Bertrand, M., Mallet, J., & Pauls, D. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01187-9 · Cited by 335
Natural History of Schizophrenia Subtypes: II. Positive and Negative Symptoms and Long-term Course
Fenton, W. S. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810350018003 · Cited by 332
Five factor model of schizophrenia: replication across samples
Lindenmayer, J. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00041-6 · Cited by 328
Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.199 · Cited by 326
The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum
Guloksuz, S., & van Os, J. (2018) · Psychological Medicine · doi:10.1017/s0033291717001775 · Cited by 325
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia
Kapur, S., & Remington, G. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.503 · Cited by 324
22q11 deletion syndrome: a genetic subtype of schizophrenia
Bassett, A. S., & Chow, E. W. C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00114-6 · Cited by 316
The Varied Outcomes of Schizophrenia
Davidson, L., & McGlashan, T. H. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200105 · Cited by 308
The diagnostic concept of schizophrenia: its history, evolution, and future prospects
Jablensky, A. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/ajablensky · Cited by 306
Javitt, D. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950190032005 · Cited by 304
Significance and Meaning of Neurological Signs in Schizophrenia: Two Decades Later
Bombin, I. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi028 · Cited by 301
Longitudinal Study of Cognitive Function in First-Episode and Recent-Onset Schizophrenia
Gold, S., Arndt, S., Nopoulos, P., O’Leary, D. S., & Andreasen, N. C. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1342 · Cited by 296
Heimer, L., Harlan, R. E., Alheid, G. F., Garcia, M. M., & de Olmos, J. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00405-8 · Cited by 288
First-Episode Psychosis: Psychopathology, Quality of Life, and Functional Outcome
Malla, A. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi031 · Cited by 288
Censits, D. M., Daniel Ragland, J., Gur, R. C., & Gur, R. E. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00091-6 · Cited by 285
Sanfilipo, M., Lafargue, T., Rusinek, H., Arena, L., Loneragan, C., Lautin, A., Feiner, D., Rotrosen, J., & Wolkin, A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.471 · Cited by 281
Anhedonia in schizophrenia and major depression: state or trait
Pelizza, L., & Ferrari, A. (2009) · Annals of General Psychiatry · doi:10.1186/1744-859x-8-22 · Cited by 271
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477313 · Cited by 270
The negative symptoms of schizophrenia: A cognitive perspective
Rector, N. A., Beck, A. T., & Stolar, N. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000503 · Cited by 268
Messinger, J. W., Trémeau, F., Antonius, D., Mendelsohn, E., Prudent, V., Stanford, A. D., & Malaspina, D. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.09.002 · Cited by 271
The Positive-Negative Distinction in Schizophrenia: Review of Natural History Validators
McGlashan, T. H. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820010063008 · Cited by 270
Neuropsychological Impairments in Deficit vs Nondeficit Forms of Schizophrenia
Buchanan, R. W. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950100052005 · Cited by 268
Subtyping schizophrenia: implications for genetic research
Jablensky, A. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001857 · Cited by 268
Buchanan, R. W., Breier, A., Kirkpatrick, B., Ball, P., & Carpenter, W. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.751 · Cited by 264
Risk Factors for Psychosis: Impaired Social and Role Functioning
Cornblatt, B. A., Carrion, R. E., Addington, J., Seidman, L., Walker, E. F., Cannon, T. D., Cadenhead, K. S., McGlashan, T. H., Perkins, D. O., Tsuang, M. T., et al. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr136 · Cited by 262
Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.351 · Cited by 260
Structural abnormalities in deficit and nondeficit schizophrenia
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.1.59 · Cited by 253
Do Patients with Schizophrenia Ever Show Periods of Recovery? A 15-Year Multi-Follow-up Study
Harrow, M. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi026 · Cited by 252
Substance use disorders in schizophrenia: review, integration, and a proposed model
Blanchard, J. (2000) · Clinical Psychology Review · doi:10.1016/s0272-7358(99)00033-1 · Cited by 240
Negative symptoms of schizophrenia: a problem that will not go away
Stahl, S. M., & Buckley, P. F. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00947.x · Cited by 195
Demjaha, A., Valmaggia, L., Stahl, D., Byrne, M., & McGuire, P. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq088 · Cited by 194
Lutgens, D., Gariepy, G., & Malla, A. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.197103 · Cited by 181
Social cognition, brain networks and schizophrenia
LEE, K.-H., FARROW, T. F. D., SPENCE, S. A., & WOODRUFF, P. W. R. (2004) · Psychological Medicine · doi:10.1017/s0033291703001284 · Cited by 190
Tandon, R., Mazzara, C., DeQuardo, J., Craig, K. A., Meador-Woodruff, J. H., Goldman, R., & Greden, J. F. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90353-n · Cited by 168
The expression and experience of emotion in schizophrenia: a study of social interactions
Aghevli, M. A., Blanchard, J. J., & Horan, W. P. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00133-1 · Cited by 165
Emotional responding in deficit and non-deficit schizophrenia
Earnst, K. S., & Kring, A. M. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00083-9 · Cited by 124
“Recently, theorists and researchers have noted the importance of distinguishing primary and sec- Ž ondary negative symptoms e.g. Carpenter et al., 1988; Buchanan et al., 1990; Fenton and Mc- Glashan, 1994; Mayerhoff et al., 1994; Samson et . al., 1995; see Earnst and Kring, 1997 for a review .”
BackgroundMethodInfluentialIs late‐onset schizophrenia a subtype of schizophrenia?
Vahia, I. V., Palmer, B. W., Depp, C., Fellows, I., Golshan, S., Kraemer, H. C., & Jeste, D. V. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01552.x · Cited by 119
Negative symptoms in first episode non‐affective psychosis
Malla, A. K., Takhar, J. J., Norman, R. M. G., Manchanda, R., Cortese, L., Haricharan, R., Verdi, M., & Ahmed, R. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.02139.x · Cited by 118
Lieberman, J. A. (1993) · British Journal of Psychiatry · doi:10.1192/s0007125000292544 · Cited by 108
The Role of Cytokines in the Pathogenesis of Schizophrenia
Dawidowski, B., Górniak, A., Podwalski, P., Lebiecka, Z., Misiak, B., & Samochowiec, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173849 · Cited by 102
Carpenter, W. T., Bustillo, J. R., Thaker, G. K., van Os, J., Krueger, R. F., & Green, M. J. (2009) · Psychological Medicine · doi:10.1017/s0033291709990286 · Cited by 99
Self-citationHo, N. F., Chong, P. L. H., Lee, D. R., Chew, Q. H., Chen, G., & Sim, K. (2019) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000207 · Cited by 89
Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia
Suzuki, T., Kanahara, N., Yamanaka, H., Takase, M., Kimura, H., Watanabe, H., & Iyo, M. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.02.021 · Cited by 81
Lee, M. R., Wehring, H. J., McMahon, R. P., Linthicum, J., Cascella, N., Liu, F., Bellack, A., Buchanan, R. W., Strauss, G. P., Contoreggi, C., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.001 · Cited by 80
Spatio-temporal luminance contrast sensitivity and visual backward masking in schizophrenia
Slaghuis, W. L. (2004) · Experimental Brain Research · doi:10.1007/s00221-003-1771-3 · Cited by 71
“Carpenter et al. (1988) proposed a further subclassification of negative symptoms into deficit syndrome, which are primary and enduring negative symptoms, and nondeficit syndrome as a further refinement of the positive- and negative-symptom distinction.”
BackgroundA latent structure analysis of the positive and negative symptoms in schizophrenia
Brekke, J. S., DeBonis, J. A., & Graham, J. W. (1994) · Comprehensive Psychiatry · doi:10.1016/0010-440x(94)90016-7 · Cited by 68
Affective modulation of the startle reflex in schizophrenic patients
Schlenker, R., Cohen, R., & Hopmann, G. (1995) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02191873 · Cited by 68
Electrodermal predictors of functional outcome and negative symptoms in schizophrenia
Schell, A. M., Dawson, M. E., Rissling, A., Ventura, J., Subotnik, K. L., Gitlin, M. J., & Nuechterlein, K. H. (2005) · Psychophysiology · doi:10.1111/j.1469-8986.2005.00300.x · Cited by 68
The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis
Taylor, S. F., Grove, T. B., Ellingrod, V. L., & Tso, I. F. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz046 · Cited by 67
Are psychiatric diagnoses of psychosis scientific and useful?: The case of schizophrenia
Van Os, J. (2010) · Journal of Mental Health · doi:10.3109/09638237.2010.492417 · Cited by 65
Dickinson, D., Pratt, D. N., Giangrande, E. J., Grunnagle, M., Orel, J., Weinberger, D. R., Callicott, J. H., & Berman, K. F. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx039 · Cited by 62
Dyck, M. S., Mathiak, K. A., Bergert, S., Sarkheil, P., Koush, Y., Alawi, E. M., Zvyagintsev, M., Gaebler, A. J., Shergill, S. S., & Mathiak, K. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00037 · Cited by 56
Riehle, M., Böhl, M. C., Pillny, M., & Lincoln, T. M. (2020) · Clinical Psychology in Europe · doi:10.32872/cpe.v2i3.2899 · Cited by 51
Revisiting the Diagnosis of Schizophrenia: Where have we been and Where are We Going?
Keller, W. R., Fischer, B. A., & Carpenter Jr., W. T. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00229.x · Cited by 46
Premorbid, clinical and cognitive correlates of primary negative symptoms in first-episode psychosis
Chang, W. C., Lau, C. F. C., Chan, S. S. I., Hui, C. L. M., Chan, S. K. W., Lee, E. H. M., Lin, J., & Chen, E. Y. H. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.05.045 · Cited by 29
BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia
Zhang, Z., Huang, J., Shen, Y., & Li, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00302 · Cited by 23
Lyngstad, S. H., Gardsjord, E. S., Simonsen, C., Engen, M. J., Romm, K. L., Melle, I., & Færden, A. (2018) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2018.07.015 · Cited by 12
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1988-05-01
- Volume
- 145
- Issue
- 5
- Pages
- 578-583
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W1694864989
- Cited by
- 1,332
- References
- 23
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.